Member Log-in

I forgot my password

Not a Member? Register

Expenditures on Vaccine-preventable Disease Surveillance: Analysis and Evaluation of Comprehensive Multi-year Plans (cMYPs) for Immunization

Despite the importance of vaccine-preventable disease (VPD) surveillance, little is known about the costs of monitoring disease. We used Comprehensive Multi-Year Plans for Immunization (cMYPs) – developed by countries following guidelines from the World Health Organization and United Nations Children’s Fund – to estimate expenditures on VPD surveillance at the country level in 2015 US Dollars (USD) in 63 low- and middle-income countries. To evaluate the reliability of cMYP estimates, we also compared cMYP data with findings from previous research studies and assessed whether countries explicitly budgeted for major categories of surveillance activities in their plans for immunization. According to our analysis of cMYPs, countries spent an annual median of $406,108 on VPD surveillance ($0.04 per capita and $1.47 per infant), with reported expenditures ranging from $1,098 (Kiribati) to $21,644,770 (Nigeria). However, the majority of countries failed to explicitly mention several key categories of surveillance activities in their plans, especially laboratory-related surveillance activities. Our results show a large amount of variation in surveillance expenditures (total, per capita, and per infant) between countries and provide insights to improve costing guidelines and practices.

Read the full paper.

You May Also Like

Case Studies: Immunization and the Role of the Private Sector

Abt Associates conducted analyses of the role of the private sector in three different settings – Benin, Georgia, and Malawi. Each analysis resulted in a report containing information on the country’s private sector health services, policy implications, and recommendations for the provision of vaccinations in the private sector. Benin | Georgia | Malawi

UNICEF Immunization Financing in MENA Middle-Income Countries

Most Middle East and North Africa (MENA) countries have high immunization coverage rates. But immunization coverage has dropped considerably in some (including Iraq, the Syrian Arab Republic and Yemen), due to the conflicts, instability and the prevailing geopolitical situation in the region. Approximately 1.3 million surviving infants in MENA missed their third dose of DTP … Continued

The Equity Impact Vaccines May Have On Averting Deaths And Medical Impoverishment In Developing Countries

A team of researchers modeled the equity impact of lives saved and medical impoverishment averted from immunization over the period 2016-30 in 41 low and middle income countries (DHS survey availability determined which countries were selected for inclusion). Of our 15 LNCT member countries, data from Armenia, Ghana, Indonesia, Nigeria, and Timor-Leste were included in … Continued

Choose a Language